Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wegener's granulomatosis.

R Y Leavitt1, A S Fauci

  • 1National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.

Current Opinion in Rheumatology
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The management of subglottic stenosis in patients with Wegener's granulomatosis.

The Laryngoscope·1992
Same author

The treatment of Wegener's granulomatosis with glucocorticoids and methotrexate.

Arthritis and rheumatism·1992
Same author

Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells.

The Journal of experimental medicine·1992
Same author

CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals.

Journal of immunology (Baltimore, Md. : 1950)·1992
Same author

Lymphokine production by B cells from normal and HIV-infected individuals.

Annals of the New York Academy of Sciences·1992
Same author

Pharmacologic regulation of HIV expression.

AIDS research and human retroviruses·1992

Wegener's granulomatosis involves respiratory tract vasculitis and glomerulonephritis. Research focuses on anti-neutrophil cytoplasmic antibodies for diagnosis and management, with ongoing debate on cyclophosphamide pulse therapy efficacy.

Area of Science:

  • Rheumatology
  • Nephrology
  • Pulmonology

Background:

  • Wegener's granulomatosis is a rare autoimmune disease affecting the respiratory tract and kidneys.
  • Its etiology remains largely unknown, presenting complex diagnostic and management challenges.

Purpose of the Study:

  • To review recent literature on Wegener's granulomatosis, focusing on clinical and pathological features.
  • To examine the role of anti-neutrophil cytoplasmic antibodies (ANCA) in diagnosis, management, and pathogenesis.
  • To discuss the current understanding of therapeutic approaches, including cyclophosphamide pulse therapy.

Main Methods:

  • Literature review of articles published during a specified period.
  • Analysis of clinical and histopathological findings from reported cases.

Related Experiment Videos

  • Evaluation of studies investigating the role of ANCA in Wegener's granulomatosis.
  • Discussion of existing therapeutic strategies and emerging treatment data.

    • Main Results:

    • Recent publications highlight pulmonary manifestations and head and neck histopathology.
    • Anti-neutrophil cytoplasmic antibodies (ANCA) are central to diagnosis, management, and understanding pathogenesis.
    • Conflicting conclusions exist regarding the efficacy of cyclophosphamide pulse therapy.

    Conclusions:

    • Wegener's granulomatosis requires comprehensive understanding of its diverse manifestations.
    • ANCA testing is crucial for accurate diagnosis and monitoring of the disease.
    • Further research is needed to clarify optimal therapeutic strategies, particularly for cyclophosphamide pulse therapy.